Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 134 participants.
Also called NCT03186729
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 134 participants
- Sponsor
- Registry
-
NCT03186729
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark, Norway, Sweden
- Registry status
- Terminated
Technical summary
Registry record NCT03186729. Randomized; single masking; primary purpose prevention. Start 2018-07-01 (actual); primary completion 2024-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
- Acronym
- STATICH
- Condition
- Cerebral Hemorrhage
- Condition
- Intracranial Hemorrhages
- Condition
- Atrial Fibrillation
- Condition
- Anticoagulant-Induced Bleeding
- Condition
- Secondary Prevention
- Intervention (Drug)
- Antithrombotic Agent
- Lead sponsor
- Oslo University Hospital
Record details
- Record id
cardio:ct-nct03186729- Content hash
5fae05cd0022c9ae9e0f004ea469fb93aeae0a575cc3f24a97a5cf45307cd20b